TRIM11 promotes breast cancer cell proliferation by stabilizing estrogen receptor α
Breast cancer is the most commonly diagnosed malignancy in female worldwide, over 70% of which are estrogen receptor α (ERα) positive. ERα has a crucial role in the initiation and progression of breast cancer and is an indicator of endocrine therapy, while endocrine resistance is an urgent problem i...
Main Authors: | Jianing Tang, Yongwen Luo, Zelin Tian, Xing Liao, Qiuxia Cui, Qian Yang, Gaosong Wu |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2020-09-01
|
Series: | Neoplasia: An International Journal for Oncology Research |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S1476558620301251 |
Similar Items
-
TRIM3 facilitates estrogen signaling and modulates breast cancer cell progression
by: Cai, Y., et al.
Published: (2022) -
The TRIMendous Role of TRIMs in Virus–Host Interactions
by: Sarah van Tol, et al.
Published: (2017-08-01) -
The determinants of chain type specificity and the mechanism of polyubiquitination by HECT E3s
by: Kim, Hyung Cheol
Published: (2011) -
Regulation of ERα Stability and Estrogen Signaling in Breast Cancer by HOIL-1
by: Jianing Ding, et al.
Published: (2021-05-01) -
TRIM16 transcription factor in prostate cancer
by: L. V. Spirina, et al.
Published: (2018-09-01)